Intracardiac Echo

DEVICE2 trials

Sponsors

EP MedSystems, Corvia Medical

Conditions

Atrial FibrillationHeart Failure

Phase 1

Intra-Cardiac Echocardiography Guided Cardioversion(ICE-CHIP) Study

CompletedNCT00281073

EP MedSystemsAtrial Fibrillation

Start: 2005-03-31End: 2008-07-31Updated: 2011-05-11

Unknown Phase

REDUCE LAP-HF RANDOMIZED TRIAL I

Active, not recruitingNCT02600234

Corvia MedicalHeart Failure

Start: 2015-12-31End: 2026-08-31Updated: 2023-03-10

Related Papers

Long term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trials.

2024-09-032 citations

Effects of Interatrial Shunt on Pulmonary Vascular Function in Heart Failure With Preserved Ejection Fraction.

2019-11-0166 citations

One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial

JAMA Cardiology2018-08-30152 citations

Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure])

Circulation2017-11-15258 citations

Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure

Circulation Heart Failure2016-06-2357 citations

A prospective comparison of cardiac imaging using intracardiac echocardiography with transesophageal echocardiography in patients with atrial fibrillation: the intracardiac echocardiography guided cardioversion helps interventional procedures study.

2010-09-1862 citations